BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update
Vancouver, British Columbia and Rehovot, Israel – January 8, 2024 – BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”), a pioneer in Botanical Synthesis technology that grows active Phyto-nutrient compositions without growing the plant, has issued a letter to shareholder partners from Chief Executive Officer, Ilan Sobel. Dear Fellow Shareholder Partners, […]
BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update Read More »